Form 4 · Filed Jul 7, 2026, 10:29 PM UTC
ETON/Eton Pharmaceuticals, Inc.
Opaleye Management Inc. — 10pct_owner
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
5 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 7, 2026 | S | sell | 20,000 | $38 | $767,456 | 2,680,000 |
| Jul 7, 2026 | S | sell | 6,685 | $38 | $256,522 | 53,315 |
| Jul 6, 2026 | S | sell | 10,000 | $38 | $380,000 | 2,700,000 |
| Jul 2, 2026 | S | sell | 65,000 | $37 | $2,430,032 | 2,710,000 |
| Jul 2, 2026 | S | sell | 25,000 | $37 | $934,628 | 60,000 |
Source: SEC EDGAR raw filing ↗ · Accession 0001493152-26-032394